KalVista Pharmaceuticals
KALV
KALV
25 hedge funds and large institutions have $61.6M invested in KalVista Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
3% less capital invested
Capital invested by funds: $63.2M → $61.6M (-$1.62M)
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
Holders
25
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$1.81M | |
| 2 | +$429K | |
| 3 | +$389K | |
| 4 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$385K |
| 5 |
DS
DRW Securities
Chicago,
Illinois
|
+$28.4K |
Top Sellers
| 1 | -$1.76M | |
| 2 | -$430K | |
| 3 | -$385K | |
| 4 |
Goldman Sachs
New York
|
-$151K |
| 5 |
JPMorgan Chase & Co
New York
|
-$77.3K |